Dr Ruth Pidsley is an NHMRC Investigator Fellow, Group Leader of the DNA Methylation Biomarkers group at the Garvan Institute of Medical Research and Conjoint Senior Lecturer at St Vincent's Clinical School, UNSW Sydney. She graduated with a degree in Human Sciences from Oxford University, before studying for an MSc/PhD at King's College London, investigating epigenetics in the human brain and neuropsychiatric disorders. In 2013 she transitioned to cancer research, joining Professor Susan Clark’s Epigenetics Research Lab at Garvan, and established her own research group in 2018. She has been awarded competitive funding for research projects from CINSW, CCNSW, Tour de Cure and NHMRC, and published more than 40 peer-reviewed articles. The research in Ruth's group focuses primarily on the role of epigenetics in prostate cancer and the tumour microenvironment. The team’s goal is to use epigenetic information to better understand prostate tumour biology and improve cancer diagnosis and prognosis, so that patients can receive the correct treatment.